Prevent Cancer Dialogue is back (in person) and better than ever! The 2022 Prevent Cancer Dialogue returns June 9-10 at the Renaissance Arlington Capital View Hotel in Arlington, Va. and we hope you’ll join us. This annual “can’t-miss” conference brings together a diversity of stakeholders from both clinical medicine and public health to spark discussion and exchange about best practices in delivering cancer screening and prevention in YOUR communities and workplaces. Click here to register and secure your spot.
The conference theme is advancing health equity through innovation. Over the course of two days, you’ll hear discussions on topics ranging from human papillomavirus (HPV) vaccination updates, frontiers in early detection, technologies that can transform health care, increased lung cancer screening rates and more! View the full Dialogue agenda and speaker lineup.
Nurses, nurse practitioners and certified health education specialists can earn continuing education credits by attending the Prevent Cancer Dialogue. The Prevent Cancer Foundation is a designated provider of continuing education contact hours (CECH) by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES®) and/or Master Certified Health Education Specialists (MCHES®) to receive up to 12.25 total Category I CECH. This activity is also pending by the Continuing Education Approval Program of the National Association of Nurse Practitioners in Women’s Health for up to 13.25 credits.
Take advantage of the "bring a friend" discount by registering yourself and another person (or more) at one time to receive 10% off each registration fee. To learn more—including additional information about the event's COVID-19 safety policies—click here. Together, we can dare to imagine a world where no one dies of cancer. Dialogue with us to help make this vision a reality!
The Prevent Cancer Foundation® is the only U.S. nonprofit organization focused solely on saving lives across all populations through cancer prevention and early detection. Through research, education, outreach and advocacy, we have helped countless people avoid a cancer diagnosis or detect their cancer early enough to be successfully treated.
The Foundation is rising to meet the challenge of reducing cancer deaths by 40% by 2035. To achieve this, we are committed to investing $20 million for innovative technologies to detect cancer early and advance multi-cancer screening, $10 million to expand cancer screening and vaccination access to medically underserved communities, and $10 million to educate the public about screening and vaccination options.
For more information, please visit www.preventcancer.org.